Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisSkin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, juvenile idiopathic arthritis, musculoskeletal system disorder, rheumatic disorderRecruitingPhase 32026-10-09NCT06668181

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UCB Biopharma SRL30

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ja0005 40072Freiburg im BreisgauGermany1
Ja0005 40100MadridSpain1
Ja0005 40356DresdenGermany1
Ja0005 40369BerlinGermany1
Ja0005 40427TübingenGermany1
Ja0005 40510Le Kremlin-BicêtreFrance1
Ja0005 40720KrakowPoland1
Ja0005 40776PoitiersFrance1
Ja0005 40777Indre-et-LoireFrance1
Ja0005 40778ParisFrance1
Ja0005 40779SendenhorstGermany1
Ja0005 40780SosnowiecPoland1
Ja0005 40781Esplugues de LlobregatSpain1
Ja0005 40782ValenciaSpain1
Ja0005 40783ManchesterUnited Kingdom1
Ja0005 40784Stoke-on-TrentUnited Kingdom1
Ja0005 40785NottinghamUnited Kingdom1
Ja0005 40786BristolUnited Kingdom1
Ja0005 40787Sankt AugustinGermany1
Ja0005 40852HamburgGermany1
Ja0005 50644MontrealCanada1
Ja0005 50645SaskatoonCanada1
Ja0005 50646CalgaryCanada1